SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical […]
VERB’s MARKET.live Adds 100 More Retail Brands to its Livestream Social Shopping Platform
LOS ALAMITOS, Calif. and LAS VEGAS, March 18, 2024 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or […]
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
Silo reports positive stability of SP-26 for time-release and dosage control SARASOTA, FL, March 18, 2024 (GLOBE NEWSWIRE) — Silo […]
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies […]
Simply Good Foods to Report Second Quarter Fiscal Year 2024 Financial Results on Thursday, April 4, 2024
DENVER, March 18, 2024 (GLOBE NEWSWIRE) — The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), […]
Mercury Announces Early Access Program for New Direct RF Multi-Chip Module Powered by AMD Versal Adaptive SoCs
ANDOVER, Mass., March 18, 2024 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical […]
Aussie Vapes Enjoys Single Highest Day of Sales in Its History
TORONTO, March 18, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), […]
Canada Carbon Receives Full Assay Results on its Asbury Property, Including 12.25%Cg over 22.50 Metres
TORONTO, March 18, 2024 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company” or “Canada Carbon” or “CCB”) (TSX-V:CCB),(FF:U7N1) is pleased […]
Genius Group Release Additional Details of FatBrain AI Transaction
SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur […]
Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
―Industry veteran with late-stage clinical development, medical affairs, and regulatory experience; well-positioned to advance losmapimod towards a potential regulatory submission […]
